Evidence map›Paper›PMID 19690217›Full record

ArticleFASEB journal : official publication of the Federation of American Societies for Experimental Biology2009

Zyxin is involved in thrombin signaling via interaction with PAR-1 receptor.

Jingyan Han, Guoquan Liu, Jasmina Profirovic, Jiaxin Niu, Tatyana Voyno-Yasenetskaya

Open access · greenAbstract read
In one paragraph

Article in FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
0.8field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Zyxin (ZYX) promotes invasion and acts as a biomarker for aggressive phenotypes of human glioblastoma multiforme.Laboratory investigation; a journal of technical methods and pathology · 2020
    Article
  6. Impedance-based cellular assays for regenerative medicine.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2018
    Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Signal transduction by protease-activated receptors.British journal of pharmacology · 2010
    Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Jingyan HanDepartment of Pharmacology (MC 868), University of Illinois at Chicago, 909 S. Wolcott Ave., Chicago, IL 60612, USA.
Guoquan Liu
Jasmina Profirovic
Jiaxin Niu
Tatyana Voyno-Yasenetskaya
University of Illinois Chicago · US

Funding

TRPC6 Regulation of Lung Endothelial Barrier FunctionP01HL060678 · NHLBI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI MALIK, ASRAR B. · 2000 to 2020
$40.1M
REGULATION OF MITOGENESIS AND APOPTOSIS BY G PROTEINSR01GM056159 · NIGMS · UNIVERSITY OF ILLINOIS AT CHICAGO · PI VOYNO-YASENETSKAYA, TATYANA A · 1999 to 2008
$2.5M
REGULATION OF MITOGENESIS AND APOPTOSIS BY G PROTEINSR55GM056159 · NIGMS · UNIVERSITY OF ILLINOIS AT CHICAGO · PI VOYNO-YASENETSKAYA, TATYANA A · 1997 to 1997
–
NHLBI NIH HHS P01 HL060678NHLBI NIH HHS P01 HL60678NIGMS NIH HHS GM56159NIGMS NIH HHS R01 GM056159NIGMS NIH HHS R55 GM056159
6 · The paper itself

Abstract

Protease-activated receptor 1 (PAR-1) mediates thrombin signaling in human endothelial cells. As a G-protein-coupled receptor, PAR-1 transmits thrombin signal through activation of the heterotrimeric G proteins, Gi, Gq, and G12/13. In this study, we demonstrated that zyxin, a LIM-domain-containing protein, is involved in thrombin-mediated actin cytoskeleton remodeling and serum response element (SRE)-dependent gene transcription. We determined that zyxin binds to the C-terminal domain of PAR-1, providing a possible mechanism of involvement of zyxin as a signal transducer in PAR-1 signaling. Data showing that disruption of PAR-1-zyxin interaction inhibited thrombin-induced stress fiber formation and SRE activation supports this hypothesis. Similarly, depletion of zyxin using siRNA inhibited thrombin-induced actin stress fiber formation and SRE-dependent gene transcription. In addition, depletion of zyxin resulted in delay of endothelial barrier restoration after thrombin treatment. Notably, down-regulation of zyxin did not affect thrombin-induced activation of RhoA or Gi, Gq, and G12/13 heterotrimeric G proteins, implicating a novel signaling pathway regulated by PAR-1 that is not mediated by G-proteins. The observation that zyxin targets VASP, a partner of zyxin in regulation of actin assembly and dynamics, to focal adhesions and along stress fibers on thrombin stimulation suggests that zyxin may participate in thrombin-induced cytoskeletal remodeling through recruitment of VASP. In summary, this study establishes a crucial role of zyxin in thrombin signaling in endothelial cells and provides evidence for a novel PAR-1 signaling pathway mediated by zyxin.

Indexed as

AnimalsCell Adhesion MoleculesChlorocebus aethiopsCOS CellsCytoskeletal ProteinsEndothelial CellsGene Expression RegulationGlycoproteinsHeterotrimeric GTP-Binding ProteinsHumansMicrofilament ProteinsPhosphoproteinsProtein TransportReceptor, PAR-1Signal TransductionThrombinCell Adhesion MoleculesCytoskeletal ProteinsGlycoproteinsHeterotrimeric GTP-Binding ProteinsMicrofilament ProteinsPhosphoproteinsReceptor, PAR-1ThrombinVasodilator-Stimulated PhosphoproteinZyxinZYX protein, human

Identifiers

PMID19690217
PMCPMC2812041
OpenAlexW2142003789

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.